NCT03940625View on ClinicalTrials.gov

Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

June 3, 2015

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Breast CancerMyocardial DamageCardiotoxicity
Interventions
DIAGNOSTIC_TEST

Cardiac MRI and echocardiography, laboratory parameters

Cardiac MRI including cine imaging (volumetric determination of LV-EF), late gadolinium enhancement, strain analysis, T1 mapping and T2 mapping Echocardiography including 3D-EF, diastolic function and strain analysis Determination of laboratory parameters including cardiac enzymes (Troponin T and high sensitivity Troponin T) and cardiac markers (BNP and NT-pro BNP)

Trial Locations (1)

40225

Division of Cardiology, Pulmonary Disease and Vascular Medicine, Düsseldorf

All Listed Sponsors
lead

Heinrich-Heine University, Duesseldorf

OTHER

NCT03940625 - Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping | Biotech Hunter | Biotech Hunter